|
⚲
|
| Ligocyte Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001400794 |
| Sale | 2008-03-18 ($29.5 M Offered, $29.5 M Sold) |
| Fund | |
| Phone | 4065852733 |
| Address | 2155 Analysis Drive Bozeman, 59718 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Larry Mikkola | |
| C Clarke | |
| Markus Goebel Md PhD | |
| Hironori Hozoji | |
| J Debethizy PhD | |
| Ivor Royston Md | |
| Ben Auspitz | |
| Donald Beeman | |
| George Kemble PhD | |
| Rob Goodwin |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Navab Alexandar Jr
✚
|
0.0 | |
|
Nav Capital S1B LP
✚
|
0.0 | |
|
Navis Asia Fund VIII, L.P.
✚
|
0.0 | |
|
Navitas Capital Co-Invest II-B, L.P.
✚
|
0.0 | |
|
Nayan Therapeutics, Inc.
✚
|
0.0 | |
|
Nayar SID
✚
|
0.0 | |
|
Naya SPV II, LLC
✚
|
0.0 | |
|
Nayawood LP
✚
|
0.0 | |
|
Nay Gary J
✚
|
0.0 | |
|
Nautic Partners IX LP
✚
|
0.0 |